We aim to apply the innovative approach and constantly seeking new ways to solve the challenge
The amendments to regulation E-1 of the BWM Convention adopted by MECP 74 requires biological efficacy testing when commissioning a BWTS on board a vessel. This amendment will come into effect on 1 of June 2022, but the MEPC has encouraged flag administrations to start with commissioning testing as soon as possible. A number of administrations are already explicitly requiring sampling and biological testing at commissioning survey, examples Cyprus, France, Gibraltar, Greece, Singapore ets.
For the biological efficacy testing, our testing team needs to go on board the vessel to take samples.
The analysis of the samples is typically performed on board the ship or at laboratory ashore.
Upon testing results are obtained, the final report covering the project outcome and explicitly following Flag and Class requirements is issued.
The samples are to be tested for viable organisms of ≥ 50 µm, ≥ 10 ÷ 50 μm and selected Bacteria.
Our broad experience in Regulatory framework, classification, ballast water treatment systems and microbiology allow to provide a qualified support.
The company is able to provide commissioning testing at the shipyard or after the vessel has left the shipyard, our mobile teams are ready to step in to the project when and where needed.
Cost effective ship life cycle management solutions for your efficient operations